Internet-based depression treatment has no long-term protective effect, study shows

The long-term outcome of a randomized controlled trial on depression treated with psychotherapy via internet is presented in the current issue of Psychotherapy and Psychosomatics. As major depressive disorder (MDD) is highly recurrent, international practice guidelines recommend maintenance antidepressant medication and/or psychological treatment after acute MDD to prevent relapse/recurrence. Since resources in clinical practice are scarce, internet-based relapse prevention programs might be a promising alternative. Indeed, small to moderate effects of internet-based interventions were found without therapist support and higher effects with therapist support.

This study examined whether adding mobile cognitive therapy to treatment as usual was clinically superior to treatment as usual alone over 24 months in remitted recurrently depressed individuals. Results showed that there were no significant effects on outcomes over 24 months, which indicates that M-CT has no long-term protective effect. This finding is in line with a recent meta-analysis demonstrating that guided and unguided internet-based treatments were effective in the short term but not beyond 6 months posttreatment.

The Authors concluded that future studies should examine the long-term effectiveness of internet-based interventions and the optimal dosage of therapist support.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
LXRβ emerges as a promising target for depression and anxiety treatments